Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of NTRK1

Gardado en:
Detalles Bibliográficos
Publicado en:JCO Precis Oncol
Main Authors: Hemming, Matthew L., Nathenson, Michael J., Lin, Jia-Ren, Mei, Shaolin, Du, Ziming, Malik, Karan, Marino-Enriquez, Adrian, Jagannathan, Jyothi P., Sorger, Peter K., Bertagnolli, Monica, Sicinska, Ewa, Demetri, George D., Santagata, Sandro
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2020
Assuntos:
Case Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7055910/
https://ncbi.nlm.nih.gov/pubmed/32133433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00287
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares